Moneycontrol
HomeNewsBusinessGovt expects bids for Air India to be lower due to COVID-19 as assets maybe devalued

Govt expects bids for Air India to be lower due to COVID-19 as assets maybe devalued

The lower valuation of Air India is also in line with valuations of other domestic airlines like Jet Airways India Ltd, and InterGlobe Aviation owned IndiGo falling in the past year

April 07, 2021 / 15:17 IST
Story continues below Advertisement
Air India

The central government expects to privatize national carrier Air India at a much lower valuation than what it was hoping for pre-pandemic.

Senior government officials in the Civil Aviation Ministry and the Finance Ministry say that the virus is expected to keep dragging the revenues and profits of the airline and reduce the valuation of some of its prized assets like landing slots and travel routes.

Story continues below Advertisement

Even then, the intent is to go ahead with the sale, as the decision makers in the government do not believe any more taxpayer money should be pumped into the ailing airline.

“We expect bids coming in for Air India to be lower than earlier expected, especially due to the second wave of the virus that has started in the country. Valuations of Air India’s fleet, landing slots, and international and domestic travel routes may also be slightly lower,” a government source told Moneycontrol.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show